Use of Valacyclovir for Herpes Simplex Virus-1 (HSV-1) Prophylaxis After Facial Resurfacing: A Randomized Clinical Trial of Dosing Regimens
- 1 January 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 26 (1) , 50-54
- https://doi.org/10.1046/j.1524-4725.2000.99166.x
Abstract
Background.Reactivation of herpes simplex virus-1 (HSV-1) after facial resurfacing has led to severe outbreaks, delayed reepitheliazation, and scarring. Current recommendations regarding the dosing of antivirals used prophylactically are based mostly on anecdotal experience. No studies have addresseKeywords
This publication has 23 references indexed in Scilit:
- Laser resurfacingCurrent Opinion in Otolaryngology & Head and Neck Surgery, 1998
- Herpes simplex: Evolving conceptsJournal of the American Academy of Dermatology, 1996
- Prevention of Facial Herpetic Infections after Chemical Peel and Dermabrasion: New Treatment Strategies in the Prophylaxis of Patients Undergoing Procedures of the Perioral AreaPlastic and Reconstructive Surgery, 1996
- Detection of Herpes simplex virus (HSV) in the saliva from 1,000 oral surgery outpatients by the polymerase chain reaction (PCR) and virus isolationJournal of Oral Pathology & Medicine, 1994
- AciclovirDrugs, 1994
- The Jessner's + TCA Peel: A Medium‐Depth Chemical PeelThe Journal of Dermatologic Surgery and Oncology, 1989
- The herpes simplex problemJournal of the American Academy of Dermatology, 1988
- The chemical peelClinics in Dermatology, 1987
- Exacerbation of Facial Herpes Simplex after Phenolic Face PeelsThe Journal of Dermatologic Surgery and Oncology, 1984
- The spectrum of antiviral activities of acyclovir in vitro and in vivoJournal of Antimicrobial Chemotherapy, 1983